TW202419091A - 布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物 - Google Patents

布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物 Download PDF

Info

Publication number
TW202419091A
TW202419091A TW112127725A TW112127725A TW202419091A TW 202419091 A TW202419091 A TW 202419091A TW 112127725 A TW112127725 A TW 112127725A TW 112127725 A TW112127725 A TW 112127725A TW 202419091 A TW202419091 A TW 202419091A
Authority
TW
Taiwan
Prior art keywords
bruton
tyrosine kinase
pharmaceutical formulations
kinase inhibitor
conditions
Prior art date
Application number
TW112127725A
Other languages
English (en)
Inventor
清華 莊
羅伯特 奎爾
曉 陳
哈里沙 艾特魯里
Original Assignee
美商製藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商製藥公司 filed Critical 美商製藥公司
Publication of TW202419091A publication Critical patent/TW202419091A/zh

Links

Abstract

本文描述布魯東氏酪胺酸激酶(Btk)抑制劑1-((R)-3-(4-胺基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基)哌啶-1-基)丙-2-烯-1-酮之醫藥調配物。亦揭示單獨或與其他治療劑組合使用該Btk抑制劑治療自體免疫疾病或病狀、異種免疫疾病或病狀、包括淋巴瘤之癌症及發炎性疾病或病狀的方法。
TW112127725A 2015-03-03 2016-03-02 布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物 TW202419091A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62/127,717 2015-03-03
US62/193,518 2015-07-16

Publications (1)

Publication Number Publication Date
TW202419091A true TW202419091A (zh) 2024-05-16

Family

ID=

Similar Documents

Publication Publication Date Title
MX2021015368A (es) Composiciones farmaceuticas de un inhibidor de tirosina cinasa de bruton.
JOP20200222A1 (ar) أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون
MX2017001671A (es) Formulaciones novedosas de un inhibidor de la tirosina cinasa de bruton.
PH12020552065A1 (en) Ibrutinib combination therapy
MX2017012411A (es) Co-cristales de un inhibidor de tirosina cinasa de bruton.
MX2017012430A (es) Formas solvatadas de un inhibidor de tirosina quinasa de bruton.
WO2016196776A3 (en) Inhibitors of bruton's tyrosine kinase
PH12015502053A1 (en) Combinations of bruton's tyrosine kinase inhibitors and cyp3a4 inhibitors
MX2019008815A (es) Sintesis de un inhibidor de tirosina quinasa de bruton.
EA201690746A1 (ru) Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии
WO2016004305A3 (en) Inhibitors of bruton's tyrosine kinase
WO2018033941A3 (en) Pharmaceutical compositions of ibrutinib
MX2019000159A (es) Pirrolo[2,3-d]piridazin-4-onas sustituidas y pirazolo[3,4-d]pirida zin-4-onas como inhibidores de la proteina quinasa.
TW202419091A (zh) 布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物
AR103832A1 (es) Formulaciones farmacéuticas de un inhibidor de tirosina quinasa de bruton
AR098210A1 (es) Combinaciones de inhibidores de la tirosina quinasa de bruton e inmunoterapias
TH1401007895A (th) สารยับยั้ง PI3K เดลต้าแบบเลือกจำเพาะ (Selective Pi3k Delta Inhibitors)